WA People
BILL · 1997–98 SESSION

HB 1633: Fairness in drug pricing

Creating fairness in drug manufacturer pricing.

Summary

  • Declares that an agency of the state may not purchase drugs from a manufacturer who engages in price discrimination. Provides that a manufacturer who violates this act or a rule adopted under this act is subject to a civil penalty of not less than one thousand dollars nor more than fifty thousand dollars for each violation, payable to the health services account.

From the Bill Digest (HB 1633), written by the Legislature's nonpartisan staff. Read the full report ↗

Did not pass Did not pass · died in committee
  1. IntroducedFeb 3, 1997
  2. Out of committeestopped here
  3. Passed House
  4. Passed Senate
  5. Governor
  6. Law
Prime sponsor
Suzette Cooke (R-47)
Introduced
February 3, 1997 in the House
Last action
January 12, 1998

Sponsors

Prime sponsor: Suzette Cooke (R-47)

18 co-sponsors (10 Democrats, 8 Republicans)

Mark Schoesler R-9Dave Anderson D-10Hans Dunshee D-39Bill Grant D-16Sandra Romero D-22Lynn Kessler D-24Mike Carrell R-28Gigi Talcott R-28Senator D-35Jim Kastama D-25Jeralita "Jeri" Costa D-38Jim Buck R-24John Koster R-39Pat Scott D-38Paul Zellinsky R-23Peggy Johnson R-35Karen Keiser D-33Senator R-15

Votes

No recorded floor votes. This measure never reached a floor vote.

History

The Legislature's online data doesn't include step-by-step history for sessions before 2001. Its final status is shown above, and the official bill page may have more.

HB 1633 in other sessions

Bill numbers restart every two years, so the same number is a different bill in each session.

Report wrong or missing information on this page